相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Metformin inhibits extracellular matrix accumulation, inflammation and proliferation of mesangial cells in diabetic nephropathy by regulating H19/miR-143-3p/TGF-β1 axis
Xu Jiang et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2020)
The PAR-1 antagonist vorapaxar ameliorates kidney injury and tubulointerstitial fibrosis
Sarah W. Y. Lok et al.
CLINICAL SCIENCE (2020)
Sarsasapogenin alleviates diabetic nephropathy through suppression of chronic inflammation by down-regulating PAR-1: In vivo and in vitro study
Zhuang-Zhuang Tang et al.
PHYTOMEDICINE (2020)
Hesperetin ameliorates diabetic nephropathy in rats by activating Nrf2/ ARE/glyoxalase 1 pathway
Ya-Jing Chen et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Protease-activated receptor-1 contributes to renal injury and interstitial fibrosis during chronic obstructive nephropathy
Maaike Waasdorp et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2019)
Overexpression of miR-582-5p Inhibits the Apoptosis of Neuronal Cells after Cerebral Ischemic Stroke Through Regulating PAR-1/Rho/Rho Axis
Hongsheng Ding et al.
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2019)
Liquiritigenin attenuates high glucose-induced mesangial matrix accumulation, oxidative stress, and inflammation by suppression of the NF-kappa B and NLRP3 inflammasome pathways
Xiaoguang Zhu et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Repression of microRNA-382 inhibits glomerular mesangial cell proliferation and extracellular matrix accumulation via FoxO1 in mice with diabetic nephropathy
Shan Wang et al.
CELL PROLIFERATION (2018)
Vorapaxar treatment reduces mesangial expansion in streptozotocin-induced diabetic nephropathy in mice
Maaike Waasdorp et al.
Oncotarget (2018)
Renoprotective effects of a factor Xa inhibitor: fusion of basic research and a database analysis
Yuya Horinouchi et al.
SCIENTIFIC REPORTS (2018)
A protease-activated receptor-1 antagonist protects against podocyte injury in a mouse model of nephropathy
Yu Guan et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2017)
Therapeutic miR-21 Silencing Ameliorates Diabetic Kidney Disease in Mice
Make Kolling et al.
MOLECULAR THERAPY (2017)
Doxycycline inhibits breast cancer EMT and metastasis through PAR-1/NF-κB/miR-17/E-cadherin pathway
Weilong Zhong et al.
ONCOTARGET (2017)
Reciprocal regulation of miR-214 and PTEN by high glucose regulates renal glomerular mesangial and proximal tubular epithelial cell hypertrophy and matrix expansion
Amit Bera et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2017)
Protease-activated receptor-1 deficiency protects against streptozotocin-induced diabetic nephropathy in mice
Maaike Waasdorp et al.
SCIENTIFIC REPORTS (2016)
A novel estrogen receptor-microRNA 190a-PAR-1-pathway regulates breast cancer progression, a finding initially suggested by genome-wide analysis of loci associated with lymph-node metastasis
Hou-Wei Chu et al.
HUMAN MOLECULAR GENETICS (2014)
miR-20b regulates expression of proteinase-activated receptor-1 (PAR-1) thrombin receptor in melanoma cells
Amina Saleiban et al.
PIGMENT CELL & MELANOMA RESEARCH (2014)
Regulation of TIMP3 in diabetic nephropathy: a role for microRNAs
Loredana Fiorentino et al.
ACTA DIABETOLOGICA (2013)
Up-regulation of protease-activated receptor-1 in diabetic glomerulosclerosis
Takumi Sakai et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Protease-activated receptor 1 mediates thrombin-dependent, cell-mediated renal inflammation in crescentic glomerulonephritis
MA Cunningham et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
分享论文
